The Use of Mebendazole in COVID-19 Patients: An Observational Retrospective Single Center Study
Background. An in-silico screen identified mebendazole with potential antiviral activity that could be a repurposed drug against SARS-CoV-2. Mebendazole is a well-tolerated and cheap antihelminthic agent that is readily available worldwide and thus could be a therapeutic tool in the fight against CO...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Advances in Virology |
| Online Access: | http://dx.doi.org/10.1155/2022/3014686 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|